MICHAEL FENNELL: Open Payments
NPI 1023765708 · ORCHARD PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,044 in 30 payments from 9 companies in 2025. Trend: 2023 $1,237 · 2024 $778 · 2025 $1,044
Food & beverage: $1,044
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 13 | $463 |
| Novartis Pharmaceuticals Corporation | 7 | $185 |
| ABBVIE INC. | 2 | $142 |
| AstraZeneca Pharmaceuticals LP | 1 | $83 |
| UCB, Inc. | 2 | $62 |
| SOBI, INC | 2 | $39 |
| Organon LLC | 1 | $30 |
| Fresenius Kabi USA, LLC | 1 | $21 |
| Bioventus LLC | 1 | $18 |
Products named: UPLIZNA, KRYSTEXXA, RINVOQ, Bimzelx, COSENTYX, Kineret, HADLIMA, OTEZLA.
Industry payments across NY — which companies pay providers there.
